By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company EyeGate Pharmaceuticals, Inc.

EyeGate Pharmaceuticals, Inc. (EYEG)

NASDAQ Currency in USD
$36.36
+$0.55
+1.52%
Last Update: 11 Sept 2025, 20:00
$27.02M
Market Cap
-15.15
P/E Ratio (TTM)
4.68%
Forward Dividend Yield
$33.92 - $37.24
52 Week Range

EYEG Stock Price Chart

Explore EyeGate Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze EYEG price movements and trends.

EYEG Company Profile

Discover essential business fundamentals and corporate details for EyeGate Pharmaceuticals, Inc. (EYEG) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

13 Feb 2015

Employees

14.00

CEO

Stephen From

Description

EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. The company is headquartered in Waltham, Massachusetts and currently employs 11 full-time employees. The firm is focused on developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye. The firm's lead product, EGP-437, incorporates a reformulated topically active corticosteroid, dexamethasone phosphate, which is delivered into the ocular tissues through its drug delivery system, the EyeGate II Delivery System. The firm is developing EGP-437 for the treatment of various inflammatory conditions of the eye, including uveitis, a debilitating form of intraocular inflammation of the anterior portion of the uvea, such as the iris and/or ciliary body, and macular edema, an abnormal thickening of the macula associated with the accumulation of excess fluids in the extracellular space of the neurosensory retina. The EyeGate II Delivery System is designed to deliver optimal quantities of drugs to the anterior or posterior segments of the eye.

EYEG Financial Timeline

Browse a chronological timeline of EyeGate Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Dividend declared on 30 May 2025

A dividend of $0.15 per share was announced, adjusted to $0.15. The dividend was paid on 5 Jun 2025.

Dividend declared on 31 Mar 2025

A dividend of $0.15 per share was announced, adjusted to $0.15. The dividend was paid on 4 Apr 2025.

Dividend declared on 28 Feb 2025

A dividend of $0.14 per share was announced, adjusted to $0.14. The dividend was paid on 6 Mar 2025.

Dividend declared on 31 Jan 2025

A dividend of $0.14 per share was announced, adjusted to $0.14. The dividend was paid on 6 Feb 2025.

Dividend declared on 6 Jan 2025

A dividend of $0.14 per share was announced, adjusted to $0.14. The dividend was paid on 5 Sept 2025.

Dividend declared on 6 Jan 2025

A dividend of $0.15 per share was announced, adjusted to $0.15. The dividend was paid on 6 Aug 2025.

Dividend declared on 6 Jan 2025

A dividend of $0.14 per share was announced, adjusted to $0.14. The dividend was paid on 7 Jul 2025.

Dividend declared on 6 Jan 2025

A dividend of $0.15 per share was announced, adjusted to $0.15. The dividend was paid on 6 May 2025.

Dividend declared on 27 Dec 2024

A dividend of $0.47 per share was announced, adjusted to $0.47. The dividend was paid on 2 Jan 2025.

Dividend declared on 29 Nov 2024

A dividend of $0.15 per share was announced, adjusted to $0.15. The dividend was paid on 5 Dec 2024.

Earnings released on 8 Nov 2024

EPS came in at -$0.81 .

Dividend declared on 31 Oct 2024

A dividend of $0.15 per share was announced, adjusted to $0.15. The dividend was paid on 6 Nov 2024.

Dividend declared on 30 Sept 2024

A dividend of $0.15 per share was announced, adjusted to $0.15. The dividend was paid on 4 Oct 2024.

Dividend declared on 30 Aug 2024

A dividend of $0.15 per share was announced, adjusted to $0.15. The dividend was paid on 6 Sept 2024.

Earnings released on 9 Aug 2024

EPS came in at -$0.53 , while revenue for the quarter reached $20.00K .

Dividend declared on 31 Jul 2024

A dividend of $0.15 per share was announced, adjusted to $0.15. The dividend was paid on 6 Aug 2024.

Dividend declared on 28 Jun 2024

A dividend of $0.15 per share was announced, adjusted to $0.15. The dividend was paid on 5 Jul 2024.

Dividend declared on 31 May 2024

A dividend of $0.15 per share was announced, adjusted to $0.15. The dividend was paid on 6 Jun 2024.

Dividend declared on 30 Apr 2024

A dividend of $0.15 per share was announced, adjusted to $0.15. The dividend was paid on 7 May 2024.

Dividend declared on 28 Mar 2024

A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 5 Apr 2024.

Dividend declared on 29 Feb 2024

A dividend of $0.15 per share was announced, adjusted to $0.15. The dividend was paid on 7 Mar 2024.

Dividend declared on 31 Jan 2024

A dividend of $0.15 per share was announced, adjusted to $0.15. The dividend was paid on 7 Feb 2024.

Dividend declared on 27 Dec 2023

A dividend of $0.09 per share was announced, adjusted to $0.09. The dividend was paid on 4 Jan 2024.

EYEG Stock Performance

Access detailed EYEG performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run